Questcor Pharmaceuticals, Inc. is a California based pharmaceutical company started in 1990 that focuses specifically on developing products for central nervous system disorders. Originally Questcor Pharmaceuticals, Inc. offered a much wider selection of products, but as they shifted their focus soley to central nervous system related developments, that had to part ways with several products.
H.P. Acthar Gel was launched by Questcor Pharmaceuticals, Inc. in 2005. It has been approved by the FDA for use in treament of acute exacerbations of multiple sclerosis. H.P. Acthar Gel is available in gel form and does not require a physician to administer.
National Organization for Rare Disorders provides Questcor Pharmaceuticals, Inc. patient assistance program. NORD offers an one year supply of H.P. Acthar Gel at a discount of 25%-100% to those who are eligible for the program. Eligibility is based off of the following requirements:
The medication must be sent to the Hospital, Physicians Office, or Pharmacy.
| Family Size | 100% | 133% | 150% | 200% | 250% | 300% |
| 1 | $10,830 | $14,404 | $16,245 | $21,660 | $27,075 | $32,490 |
| 2 | $14,570 | $19,378 | $21,855 | $29,140 | $36,425 | $43,710 |
| 3 | $18,310 | $24,352 | $27,465 | $36,620 | $45,775 | $54,930 |
| 4 | $22,050 | $29,327 | $33,075 | $44,100 | $55,125 | $66,150 |
| 5 | $25,790 | $34,301 | $38,685 | $51,580 | $64,475 | $77,370 |
| 6 | $29,530 | $39,275 | $44,295 | $59,060 | $73,825 | $88,590 |
| 7 | $33,270 | $44,249 | $49,905 | $66,540 | $83,175 | $99,810 |
| 8 | $37,010 | $49,223 | $55,515 | $74,020 | $92,525 | $111,030 |
| For each additional family member | $3,740 | $4,974 | $5,610 | $7,480 | $9,350 | $11,220 |
Fill out the program enrollment form located to your right. If you don’t see an enrollment form available please call Questcor Pharmaceuticals program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.